Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

DHSC updates June 2023 price concessions after CPE members report medicine pricing issues

Department of Health and Social Care (DHSC) has updated the final price concessions for June 2023, following a discussion by Community Pharmacy England regarding medicine pricing issues reported by pharmacy owners (its members).

A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.


Community Pharmacy England encouraged pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website along with full details of the supplier and price paid for any products sourced above the Drug Tariff price.

The association will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

“Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system,” said CPE.

One of the solutions agreed between CPE and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us.

CPE is also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate.

Full list below:

DrugPack sizePrice concession
* Alginate raft-forming oral suspension sugar free500£3.80
Amiloride 5mg tablets28£13.46
Amoxicillin 125mg/5ml oral suspension sugar free100£2.68
Benzoyl peroxide 5% / Clindamycin 1% gel60£22.22
Buprenorphine 8mg sublingual tablets sugar free7£11.36
Calamine lotion200£1.86
Chloramphenicol 0.5% eye drops10£12.51
Chlorphenamine 2mg/5ml oral solution sugar free150£4.01
Clotrimazole 500mg pessary and Clotrimazole 2% cream1£10.79
Co-careldopa 12.5mg/50mg tablets90£4.93
Co-trimoxazole 80mg/400mg tablets28£2.34
Docusate 50mg/5ml oral solution sugar free300£18.81
Flucloxacillin 250mg capsules28£2.45
Isoniazid 100mg tablets28£60.00
Ivabradine 5mg tablets56£28.33
Letrozole 2.5mg tablets14£6.66
Methylphenidate 5mg tablets30£3.45
Mometasone 0.1% cream30£3.60
Mycophenolate mofetil 500mg tablets50£7.69
Pantoprazole 20mg gastro-resistant tablets28£6.62
Pantoprazole 40mg gastro-resistant tablets28£9.23
Paracetamol 500mg effervescent tablets100£10.34
Pregabalin 300mg capsules56£4.02
Promethazine hydrochloride 25mg tablets56£29.32
Quinine sulfate 200mg tablets28£7.97
Risperidone 500microgram tablets20£2.98
Rosuvastatin 20mg tablets28£4.98
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules20£11.04
Tacrolimus 0.1% ointment60£41.69
Tacrolimus 0.1% ointment30£22.36
Tamsulosin 400microgram / Dutasteride 500microgram capsules30£14.53
Tolterodine 2mg tablets56£3.55
Topiramate 100mg tablets60£16.53
Tramadol 37.5mg / Paracetamol 325mg tablets60£7.38
Trazodone 50mg capsules84£3.45
Venlafaxine 75mg tablets56£11.51
Zolmitriptan 2.5mg tablets6£18.85
Zolmitriptan 2.5mg tablets12£37.70

More For You

Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less
Scotland's digital patient care record

The amendment ensures that every person who receives health care or a social service in Scotland will have a digital care record

Pic credit: iStock

Scotland's move to create digital patient care record hailed

The Royal Pharmaceutical Society (RPS) in Scotland has welcomed the decision of the Scottish Parliament to create an integrated digital patient care record.

The move came during a debate on the Care Reform (Scotland) Bill on Tuesday (10), when Jackie Baillie tabled an amendment to ensure that every person who receives health care or a social service in Scotland has a digital care record.

Keep ReadingShow less
A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less